Loading...

Purified anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
1-M1slash70_Purified_042706
C57BL/6 mouse bone marrow cells were stained with purified CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by anti-rat IgG FITC (gated on total cells).
  • 1-M1slash70_Purified_042706
    C57BL/6 mouse bone marrow cells were stained with purified CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by anti-rat IgG FITC (gated on total cells).
  • 2-M170_Pure_CD11b_Antibody_IHC_102418
    Fresh, frozen mouse spleen was stained with purified CD11b clone M1/70 conjugated and detected with a Cy5 CODEX™ oligonucleotide duplex (red). Samples were counterstained with TCR FITC (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
101201 50 µg 24€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101202 500 µg 92€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, CyTOF® - Verified
IP, ICC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Peterson EJ, et al. 2019. Mol Syst Biol. 15:e8584. PubMed
  2. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  3. Tong CF, et al. 2018. Am J Physiol Cell Physiol. 315:C409. PubMed
  4. Li F, et al. 2020. EMBO J. 39:e103205. PubMed
  5. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  6. Doll JR, et al. 2020. PLoS Pathog. 16:e1008296. PubMed
  7. Yu H, et al. 2020. Front Immunol. 11:1773. PubMed
  8. Cai S, et al. 2020. Sci Rep. 10:14249. PubMed
  9. Calcagno DM, et al. 2020. Sci Immunol. 5: . PubMed
  10. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  11. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  12. Moore J, et al. 2022. Cancer Res. 82:365. PubMed
  13. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  14. Xiong T, et al. 2022. Cancer Sci. 113:1955. PubMed
  15. Campisi L, et al. 2022. Nature. 606:945. PubMed
  16. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  17. Zhao J, et al. 2022. J Clin Invest. 132: . PubMed
  18. Gavish A, et al. 2023. iScience. 26:105826. PubMed
  19. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  20. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  21. Shirai T, et al. 2022. Cancer Sci. 113:3710. PubMed
  22. Chen W, et al. 2023. JCI Insight. 8:. PubMed
  23. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  24. Kang YA, et al. 2023. J Exp Med. 220:. PubMed
  25. Diray-Arce J, et al. 2023. Cell Rep Med. 4:101079. PubMed
  26. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  27. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  28. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  29. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  30. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  31. Taki M, et al. 2018. Nat Commun. 1.545138889. PubMed
  32. Vinaik R, et al. 2019. Am J Physiol Endocrinol Metab. 317:E751. PubMed
  33. Chung MI, et al. 2018. Am J Respir Cell Mol Biol. 59:706. PubMed
  34. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  35. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  36. Shirakawa K, et al. 2017. PLoS One. 12:e0186303. PubMed
  37. Zhou LJ et al. 2019. Cell Rep. 27(13):3844-3859 . PubMed
  38. Yonemitsu K, et al. 2022. Sci Rep. 12:12007. PubMed
  39. Pilling D, et al. 2022. Respir Res. 23:215. PubMed
  40. Bajaña S, et al. 2021. Front Immunol. 11:577718. PubMed
  41. Zhao J, et al. 2021. JCI Insight. 6:. PubMed
  42. Larson-Casey JL, et al. 2021. FASEB J. 35:e21675. PubMed
  43. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  44. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  45. Weidner H, et al. 2020. JCI Insight. 5:00. PubMed
  46. Kim D, et al. 2008. Blood. 112:1109. PubMed
  47. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  48. Bachran C, et al. 2017. Sci Rep.. 10.1038/s41598-017-17948-0. PubMed
  49. Wagner J et al. 2019. Cell. 177(5):1330-1345 . PubMed
  50. Peng J, et al. 2019. Mol Brain. 12:71. PubMed
  51. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  52. Goel S, et al. 2017. Nature. 548:471. PubMed
  53. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  54. Leyva-Castillo JM, et al. 2020. Clin Immunol. 218:108511. PubMed
  55. Tang B, et al. 2019. Oncolytic Virother. 8:03. PubMed
  56. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  57. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  58. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  59. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  60. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  61. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  62. Nguyen N, et al. 2022. iScience. 25:103679. PubMed
  63. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  64. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  65. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  66. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  67. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  68. Bredehöft J, et al. 2022. J Inflamm Res. 15:509. PubMed
  69. Tian D, et al. 2020. FASEB J. 34:3367. PubMed
  70. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  71. Peng J, et al. 2016. Nat Commun. 7:12029. PubMed
  72. Liu T, et al. 2020. Sci Adv. 6:eaay1497. PubMed
  73. Haney MS, et al. 2018. Nat Genet. 50:1716. PubMed
  74. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  75. Rissiek B, et al. 2017. Sci Rep. . 10.1038/s41598-017-16613-w. PubMed
  76. Lee JH, et al. 2022. iScience. 25:104166. PubMed
  77. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  78. Tal MC, et al. 2020. MBio. 11:00. PubMed
  79. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  80. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  81. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  82. Matsuhira T, et al. 2021. Biochem Biophys Rep. 28:101118. PubMed
  83. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  84. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  85. Gomi M, et al. 2021. Mol Ther. 29:225. PubMed
  86. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  87. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  88. Si Y, et al. 2020. Sci Adv. 6:eaaw7713. PubMed
  89. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  90. Yang C, et al. 2019. MBio. 10:e00595-19. PubMed
  91. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  92. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  93. Guiducci E, et al. 2018. Front Immunol. 1.467361111. PubMed
  94. Guo Y, et al. 2008. Blood. 112:480. PubMed
  95. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  96. Manni M, et al. 2018. Nat Immunol. 1.074305556. PubMed
  97. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  98. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  99. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  100. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  101. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  102. Jiang L, et al. 2022. Front Immunol. 12:730438. PubMed
  103. Sato Y, et al. 2021. BMC Cancer. 21:1222. PubMed
  104. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  105. Muraleedharan A, et al. 2021. Glia. 69:697. PubMed
  106. Bednarczyk M, et al. 2021. Int J Mol Sci. 22:. PubMed
  107. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  108. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  109. Lai JF, et al. 2020. J Allergy Clin Immunol. 146:1406. PubMed
  110. Vukman KV, et al. 2020. J Extracell Vesicles. 10:e12023. PubMed
  111. Francis M, et al. 2017. Toxicol Sci. 155(1):182-195. PubMed
  112. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  113. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  114. Napimoga M, et al. 2008. J Immunol. 180:609. PubMed
  115. Wicki S, et al. 2018. Int J Mol Sci. 1.266666667. PubMed
  116. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  117. Hakamivala A, et al. 2020. Bioact Mater. 5:142. PubMed
  118. Zhong X, et al. 2020. Proc Natl Acad Sci U S A. 8563:117. PubMed
  119. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  120. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  121. Kapellos TS, et al. 2017. Mediators Inflamm. 2017:4315412. PubMed
  122. Umemoto T, et al. 2017. EMBO J. 36:2390. PubMed
  123. Kim SJ, et al. 2017. Nat Immunol. 18:1016. PubMed
  124. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  125. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  126. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  127. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  128. Manabe T, et al. 2021. J Neurochem. 159:525. PubMed
  129. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  130. Lim CS, et al. 2020. Front Immunol. 11:1186. PubMed
  131. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  132. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  133. You X, et al. 2022. Front Genet. 12:790990. PubMed
  134. Coden ME, et al. 2020. J Immunol. 204:438. PubMed
  135. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  136. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  137. Nascimento DC, et al. 2017. Nat Commun. 8:14919. PubMed
  138. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  139. Majer O, et al. 2019. Nature. 575:366. PubMed
  140. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  141. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  142. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  143. Huang S, et al. 2020. Cell Rep. 33:108394. PubMed
  144. Daley D, et al. 2017. Nat Med. 23:556. PubMed
  145. Hsieh JY, et al. 2019. APL Bioeng. 3:016103. PubMed
  146. Madsen D, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.12.011. PubMed
  147. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  148. Meyer-Lindemann U, et al. 2022. Front Immunol. 13:898690. PubMed
  149. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  150. Li J, et al. 2021. Front Immunol. 12:710406. PubMed
  151. Yi MH, et al. 2020. Brain Behav Immun. 92:78. PubMed
  152. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  153. Hoffmann FM, et al. 2018. Front Immunol. 9:1046. PubMed
  154. Baumgartner C, et al. 2010. J Immunol. 184:573. PubMed
  155. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  156. Nguyen CH, et al. 2020. Biomedicines. 8:. PubMed
  157. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  158. Speir M, et al. 2020. Nat Immunol. 21:54. PubMed
  159. Kikuchi A, et al. 2020. Am J Pathol. 190:2080. PubMed
  160. Freeman SA, et al. 2020. Science. 367:301. PubMed
  161. Galbas T, et al. 2017. J Immunol. 198(2):852-861. PubMed
  162. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  163. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  164. Ding L, et al. 2022. Nanoscale. . PubMed
  165. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  166. Vahsen BF, et al. 2022. Sci Rep. 12:12606. PubMed
  167. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  168. Wang Y, et al. 2019. Biomed Res Int. 2019:5756189. PubMed
  169. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  170. Elgazar-Carmon V, et al. 2008. J Lipid Res. 49:1849. PubMed
  171. Yamasaki T, et al. 2018. J Virol. 92:e01458. PubMed
  172. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  173. Wu W, et al. 2020. Brain Behav Immun. 89:245. PubMed
  174. Qiu Z, et al. 2022. Cancer Discov. 12:502. PubMed
  175. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  176. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  177. Takeuchi Y, et al. 2021. Sci Rep. 11:18679. PubMed
  178. Feng L, et al. 2019. Glia. 67:1434. PubMed
  179. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  180. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  181. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  182. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  183. Nicolas-Boluda A, et al. 2021. eLife. 10:00. PubMed
  184. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  185. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  186. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  187. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  188. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  189. Stotesbury C, et al. 2020. Aging Cell. 19:e13170. PubMed
  190. Wen J, et al. 2021. PLoS Pathog. 17:e1009738. PubMed
  191. Murenu E, et al. 2021. Mol Ther Methods Clin Dev. 20:587. PubMed
  192. Murenu E, et al. 2021. Int J Mol Sci. 22:. PubMed
  193. Karuppuchamy T, et al. 2020. Inflamm Bowel Dis. 216:26. PubMed
  194. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  195. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
  196. Chevrier S, et al. 2021. Cell Reports Medicine. 2(1):100166. PubMed
  197. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  198. Sun Y, et al. 2015. Proc Natl Acad Sci U S A. 112: 10401-10406. PubMed
  199. Olver S, et al. 2005. Cancer Res. 66:571. PubMed
  200. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  201. Andrews AR, et al. 2019. Cancer Cell Int. 0.955555556. PubMed
  202. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  203. Chevrier S, et al. 2018. Cell Syst. 0.675. PubMed
  204. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  205. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  206. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  207. Hsieh YL, et al. 2019. Cell Reports. 29(8):2134-2143.e7. PubMed
  208. Zheng C, et al. 2021. J Extracell Vesicles. 10:e12109. PubMed
  209. Larson–Casey JL, et al. 2019. J Clin Invest. 129:4962. PubMed
  210. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  211. Ito Y, et al. 2018. J Exp Med. 215:2617. PubMed
  212. Regan–Komito D, et al. 2017. Front Immunol. 1.459027778. PubMed
  213. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  214. Torika N, et al. 2018. CNS Neurosci Ther. 24:231. PubMed
  215. Zhou N et al. 2018. Protein & cell. 10(2):87-103 . PubMed
  216. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  217. Flores I, et al. 2021. Hum Mol Genet. Online ahead of print. PubMed
  218. Li Y, et al. 2021. Life Sci Alliance. 4:. PubMed
  219. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  220. Li X, et al. 2020. J Clin Invest. 130:4182. PubMed
  221. Kang SH, et al. 2018. Oncoimmunology. 8:e1515057. PubMed
  222. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  223. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
RRID
AB_312784 (BioLegend Cat. No. 101201)
AB_312785 (BioLegend Cat. No. 101202)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS B550™ anti-mouse/human CD11b M1/70 FC
Spark YG™ 581 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS V475™ anti-mouse/human CD11b M1/70 FC
StarBright UltraViolet 575 anti-mouse/human CD11b M1/70 FC
StarBright UltraViolet 740 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 4    Revision Date: 12.13.2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account